Research has increasingly shown that MMPs, particularly MMP-2 and MMP-9, influence immune cell trafficking, cytokine release, and immune suppression in brain tumors, potentially by modulating the expression and activity of immune checkpoint molecules [161,162]. This evidence concerns the gene MMP9 and brain neoplasm.